Economic Impact of Therapeutic Choices: The Case of Incretins

Economic Impact of Therapeutic Choices: The Case of Incretins

Bibliographic Details
Main Author:	Roberto Ravasio
Format:	Article
Language:	English
Published:	AboutScience Srl 2021-07-01
Series:	Global & Regional Health Technology Assessment
Online Access:	https://journals.aboutscience.eu/index.php/grhta/article/view/317

Similar Items

Incretins today: multiple effects and therapeutic potential
by: Oksana V. Tsygankova, et al.
Published: (2019-04-01)

Inflammation and Incretins
by: Amitabh Hatwal
Published: (2012-01-01)

Incretin Hormones and Type 2 Diabetes—Mechanistic Insights and Therapeutic Approaches
by: Geke Aline Boer, et al.
Published: (2020-12-01)

Incretins and SGLT-2i Therapy of Type 2 Diabetes – Real Life Study of Their Therapeutic and Economic Effects
by: Zornitsa Mitkova, et al.
Published: (2019-04-01)

Pleiotropic effects of incretins
by: Vishal Gupta
Published: (2012-01-01)

Stimulation of incretin secreting cells
by: Ramona Pais, et al.
Published: (2016-02-01)

The Origin and Understanding of the Incretin Concept
by: Jens F. Rehfeld
Published: (2018-07-01)

Incretins in patients with rheumatoid arthritis
by: Beatriz Tejera-Segura, et al.
Published: (2017-10-01)

Incretin hormones as immunomodulators of atherosclerosis
by: Nuria eAlonso, et al.
Published: (2012-09-01)

Understanding the Cardiovascular Effects of Incretin
by: Ji Sung Yoon, et al.
Published: (2011-10-01)

Bariatric Surgery: It's Not Just Incretins!
by: Ferraz-Bannitz, R., et al.
Published: (2022)

Incretin-based therapy: renal effects
by: Anton Ivanovich Korbut, et al.
Published: (2016-01-01)

Mechanisms of neuroprotective action of incretin mimetics
by: Timur Dmitrievich Vlasov, et al.
Published: (2016-01-01)

Incretin Effects of Momordica charantia L.
by: Ting-Ni Huang, et al.
Published: (2010)

Incretin mimetics: a novel therapeutic option for patients with type 2 diabetes – a review
by: Knop FK, et al.
Published: (2010-05-01)

Influence of diabetes surgery on gut hormones and incretins
by: D. Papamargaritis, et al.
Published: (2013-01-01)

Role of incretins in the pathogenesis of type 2 diabetes
by: Radojčin Dragan, et al.
Published: (2018-01-01)

Role of Incretin Axis in Inflammatory Bowel Disease
by: Lihua Duan, et al.
Published: (2017-12-01)

Type 2 diabetes mellitus and the cardiometabolic syndrome: impact of incretin-based therapies
by: Stanley Schwartz, et al.
Published: (2010-07-01)

Type 2 diabetes mellitus and the cardiometabolic syndrome: impact of incretin-based therapies
by: Schwartz S
Published: (2010-07-01)

Incretin mimetics: a novel therapeutic option for patients with type 2 diabetes &ndash; a review
by: Katrine B Hansen, et al.
Published: (2010-05-01)

Impact of Incretin Hormone Receptors on Insulin-Independent Glucose Disposal in Model Experiments in Mice
by: Tina Ovlund, et al.
Published: (2021-06-01)

Role of fasting duration and weekday in incretin and glucose regulation
by: Kim K B Clemmensen, et al.
Published: (2020-04-01)

Effects of meal and incretins in the regulation of splanchnic blood flow
by: Jukka Koffert, et al.
Published: (2017-04-01)

Models for Incretin Research: From the Intestine to the Whole Body
by: Tae Jung Oh
Published: (2016-03-01)

Effects of Incretin-Based Therapies on Diabetic Microvascular Complications
by: Yu Mi Kang, et al.
Published: (2017-09-01)

Incretin-Based Therapy for Prevention of Diabetic Vascular Complications
by: Akira Mima
Published: (2016-01-01)

Incretin Learning and Excellence Academy for Diabetes (iLEAD)
by: Sarita Bajaj, et al.
Published: (2016-01-01)

Renoprotective Effects of Incretin-Based Therapy in Diabetes Mellitus
by: Habib Yaribeygi, et al.
Published: (2021-01-01)

The associations of incretin hormone concentration with gestational diabetes mellitus
by: Tatiana V. Saprina, et al.
Published: (2016-04-01)

Mechanisms underlying nutrient stimulated incretin hormone secretion
by: Parker, Helen Elizabeth
Published: (2010)

Economic evaluation of therapeutic sequences in the treatment of patients with chronic lymphocytic leukemia and coexisting conditions
by: Antonio Cuneo, et al.
Published: (2017-10-01)

The incretin pathway as a therapeutic target in diabetic kidney disease: a clinical focus on GLP-1 receptor agonists
by: Michaël J. B. van Baar, et al.
Published: (2019-07-01)

Structural basis for GPR40 allosteric agonism and incretin stimulation
by: Joseph D. Ho, et al.
Published: (2018-04-01)

Incretin Hormones in Obesity and Related Cardiometabolic Disorders: The Clinical Perspective
by: Joanna Michałowska, et al.
Published: (2021-01-01)

Pathogenesis and management of postprandial hyperglycemia: role of incretin-based therapies
by: Gerich J
Published: (2013-12-01)

Discovery of dual-action membrane-anchored modulators of incretin receptors.
by: Jean-Philippe Fortin, et al.
Published: (2011-01-01)

Postprandial hyperlipidemia, endothelial dysfunction and cardiovascular risk: focus on incretins
by: Koska Juraj, et al.
Published: (2011-07-01)

Incretin response in Asian type 2 diabetes: Are Indians different?
by: Awadhesh Kumar Singh
Published: (2015-01-01)

Uncertainties around incretin-based therapies: A literature review
by: Bader Al Tulaihi, et al.
Published: (2017-01-01)

Cannot write session to /tmp/vufind_sessions/sess_shsr3e5odb1isk1aq1mfqjj3um